Quality of Evidence-Based Guidelines for Transfusion of Red Blood Cells and Plasma

A Systematic Review

Katerina Pavenski, Simon Stanworth, Mark Fung, Erica M. Wood, Joanne Pink, Michael F. Murphy, Heather Hume, Susan Nahirniak, Kathryn E. Webert, Susano Tanael, Denise Landry, Nadine Shehata, for the International Collaboration for Transfusion Medicine Guidelines (ICTMG)

Research output: Contribution to journalReview ArticleResearchpeer-review

6 Citations (Scopus)

Abstract

Many transfusion guidelines are available, but little appraisal of their quality has been undertaken. The quality of guidelines may potentially influence adoption. Our aim was to determine the quality of evidence-based transfusion guidelines (EBG) for red cells and plasma, using the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument, and assess duplication and consistency of recommendations. MEDLINE and EMBASE were systematically searched for EBG from 2005 to June 3, 2016. Citations were reviewed for inclusion in duplicate. A guideline was included if it had a specified clinical question, described a systematic search strategy, included critical appraisal of the literature and a description of how recommendations were developed. Four to six physicians used AGREE II to appraise each guideline. Median and scaled scores were calculated, with each item scored on a scale of one to seven, seven representing the highest score. Of 6174 citations, 30 guidelines met inclusion criteria. Twenty six guidelines had recommendations for red cells and 18 included recommendations for plasma use. The median score, the scaled score and the interquartile range of the scaled score were: scope and purpose: median score 5, scaled score 60%, IQR (49–74%); stakeholder involvement 4, 43%, (33–49%); rigor of development 4, 41%, (19–59%); clarity of presentation 5, 69%, (52–81%); applicability 1, 16%, (9–23%); editorial independence 3, 43%, (20–58%). Sixteen guidelines were evaluated to have a scaled domain score of 50% or less. Variations in recommendations were found for the use of hemoglobin triggers for red cell transfusion in patients with acute coronary syndromes and for plasma use for patients with bleeding. Our findings document, limited rigor in guideline development and duplication and inconsistencies in recommendations for the same topic. The process of developing guidelines for red cells and plasma transfusion can be enhanced to improve implementation.

Original languageEnglish
Pages (from-to)135-143
Number of pages9
JournalTransfusion Medicine Reviews
Volume32
Issue number3
DOIs
Publication statusPublished - 1 Jul 2018

Keywords

  • AGREE II
  • Guidelines
  • Plasma
  • Quality
  • Rbc

Cite this

Pavenski, K., Stanworth, S., Fung, M., Wood, E. M., Pink, J., Murphy, M. F., ... for the International Collaboration for Transfusion Medicine Guidelines (ICTMG) (2018). Quality of Evidence-Based Guidelines for Transfusion of Red Blood Cells and Plasma: A Systematic Review. Transfusion Medicine Reviews, 32(3), 135-143. https://doi.org/10.1016/j.tmrv.2018.05.004
Pavenski, Katerina ; Stanworth, Simon ; Fung, Mark ; Wood, Erica M. ; Pink, Joanne ; Murphy, Michael F. ; Hume, Heather ; Nahirniak, Susan ; Webert, Kathryn E. ; Tanael, Susano ; Landry, Denise ; Shehata, Nadine ; for the International Collaboration for Transfusion Medicine Guidelines (ICTMG). / Quality of Evidence-Based Guidelines for Transfusion of Red Blood Cells and Plasma : A Systematic Review. In: Transfusion Medicine Reviews. 2018 ; Vol. 32, No. 3. pp. 135-143.
@article{f0d09054bdad42029552c4f53359f770,
title = "Quality of Evidence-Based Guidelines for Transfusion of Red Blood Cells and Plasma: A Systematic Review",
abstract = "Many transfusion guidelines are available, but little appraisal of their quality has been undertaken. The quality of guidelines may potentially influence adoption. Our aim was to determine the quality of evidence-based transfusion guidelines (EBG) for red cells and plasma, using the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument, and assess duplication and consistency of recommendations. MEDLINE and EMBASE were systematically searched for EBG from 2005 to June 3, 2016. Citations were reviewed for inclusion in duplicate. A guideline was included if it had a specified clinical question, described a systematic search strategy, included critical appraisal of the literature and a description of how recommendations were developed. Four to six physicians used AGREE II to appraise each guideline. Median and scaled scores were calculated, with each item scored on a scale of one to seven, seven representing the highest score. Of 6174 citations, 30 guidelines met inclusion criteria. Twenty six guidelines had recommendations for red cells and 18 included recommendations for plasma use. The median score, the scaled score and the interquartile range of the scaled score were: scope and purpose: median score 5, scaled score 60{\%}, IQR (49–74{\%}); stakeholder involvement 4, 43{\%}, (33–49{\%}); rigor of development 4, 41{\%}, (19–59{\%}); clarity of presentation 5, 69{\%}, (52–81{\%}); applicability 1, 16{\%}, (9–23{\%}); editorial independence 3, 43{\%}, (20–58{\%}). Sixteen guidelines were evaluated to have a scaled domain score of 50{\%} or less. Variations in recommendations were found for the use of hemoglobin triggers for red cell transfusion in patients with acute coronary syndromes and for plasma use for patients with bleeding. Our findings document, limited rigor in guideline development and duplication and inconsistencies in recommendations for the same topic. The process of developing guidelines for red cells and plasma transfusion can be enhanced to improve implementation.",
keywords = "AGREE II, Guidelines, Plasma, Quality, Rbc",
author = "Katerina Pavenski and Simon Stanworth and Mark Fung and Wood, {Erica M.} and Joanne Pink and Murphy, {Michael F.} and Heather Hume and Susan Nahirniak and Webert, {Kathryn E.} and Susano Tanael and Denise Landry and Nadine Shehata and {for the International Collaboration for Transfusion Medicine Guidelines (ICTMG)}",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.tmrv.2018.05.004",
language = "English",
volume = "32",
pages = "135--143",
journal = "Transfusion Medicine Reviews",
issn = "0887-7963",
publisher = "Elsevier",
number = "3",

}

Pavenski, K, Stanworth, S, Fung, M, Wood, EM, Pink, J, Murphy, MF, Hume, H, Nahirniak, S, Webert, KE, Tanael, S, Landry, D, Shehata, N & for the International Collaboration for Transfusion Medicine Guidelines (ICTMG) 2018, 'Quality of Evidence-Based Guidelines for Transfusion of Red Blood Cells and Plasma: A Systematic Review', Transfusion Medicine Reviews, vol. 32, no. 3, pp. 135-143. https://doi.org/10.1016/j.tmrv.2018.05.004

Quality of Evidence-Based Guidelines for Transfusion of Red Blood Cells and Plasma : A Systematic Review. / Pavenski, Katerina; Stanworth, Simon; Fung, Mark; Wood, Erica M.; Pink, Joanne; Murphy, Michael F.; Hume, Heather; Nahirniak, Susan; Webert, Kathryn E.; Tanael, Susano; Landry, Denise; Shehata, Nadine; for the International Collaboration for Transfusion Medicine Guidelines (ICTMG).

In: Transfusion Medicine Reviews, Vol. 32, No. 3, 01.07.2018, p. 135-143.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Quality of Evidence-Based Guidelines for Transfusion of Red Blood Cells and Plasma

T2 - A Systematic Review

AU - Pavenski, Katerina

AU - Stanworth, Simon

AU - Fung, Mark

AU - Wood, Erica M.

AU - Pink, Joanne

AU - Murphy, Michael F.

AU - Hume, Heather

AU - Nahirniak, Susan

AU - Webert, Kathryn E.

AU - Tanael, Susano

AU - Landry, Denise

AU - Shehata, Nadine

AU - for the International Collaboration for Transfusion Medicine Guidelines (ICTMG)

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Many transfusion guidelines are available, but little appraisal of their quality has been undertaken. The quality of guidelines may potentially influence adoption. Our aim was to determine the quality of evidence-based transfusion guidelines (EBG) for red cells and plasma, using the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument, and assess duplication and consistency of recommendations. MEDLINE and EMBASE were systematically searched for EBG from 2005 to June 3, 2016. Citations were reviewed for inclusion in duplicate. A guideline was included if it had a specified clinical question, described a systematic search strategy, included critical appraisal of the literature and a description of how recommendations were developed. Four to six physicians used AGREE II to appraise each guideline. Median and scaled scores were calculated, with each item scored on a scale of one to seven, seven representing the highest score. Of 6174 citations, 30 guidelines met inclusion criteria. Twenty six guidelines had recommendations for red cells and 18 included recommendations for plasma use. The median score, the scaled score and the interquartile range of the scaled score were: scope and purpose: median score 5, scaled score 60%, IQR (49–74%); stakeholder involvement 4, 43%, (33–49%); rigor of development 4, 41%, (19–59%); clarity of presentation 5, 69%, (52–81%); applicability 1, 16%, (9–23%); editorial independence 3, 43%, (20–58%). Sixteen guidelines were evaluated to have a scaled domain score of 50% or less. Variations in recommendations were found for the use of hemoglobin triggers for red cell transfusion in patients with acute coronary syndromes and for plasma use for patients with bleeding. Our findings document, limited rigor in guideline development and duplication and inconsistencies in recommendations for the same topic. The process of developing guidelines for red cells and plasma transfusion can be enhanced to improve implementation.

AB - Many transfusion guidelines are available, but little appraisal of their quality has been undertaken. The quality of guidelines may potentially influence adoption. Our aim was to determine the quality of evidence-based transfusion guidelines (EBG) for red cells and plasma, using the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument, and assess duplication and consistency of recommendations. MEDLINE and EMBASE were systematically searched for EBG from 2005 to June 3, 2016. Citations were reviewed for inclusion in duplicate. A guideline was included if it had a specified clinical question, described a systematic search strategy, included critical appraisal of the literature and a description of how recommendations were developed. Four to six physicians used AGREE II to appraise each guideline. Median and scaled scores were calculated, with each item scored on a scale of one to seven, seven representing the highest score. Of 6174 citations, 30 guidelines met inclusion criteria. Twenty six guidelines had recommendations for red cells and 18 included recommendations for plasma use. The median score, the scaled score and the interquartile range of the scaled score were: scope and purpose: median score 5, scaled score 60%, IQR (49–74%); stakeholder involvement 4, 43%, (33–49%); rigor of development 4, 41%, (19–59%); clarity of presentation 5, 69%, (52–81%); applicability 1, 16%, (9–23%); editorial independence 3, 43%, (20–58%). Sixteen guidelines were evaluated to have a scaled domain score of 50% or less. Variations in recommendations were found for the use of hemoglobin triggers for red cell transfusion in patients with acute coronary syndromes and for plasma use for patients with bleeding. Our findings document, limited rigor in guideline development and duplication and inconsistencies in recommendations for the same topic. The process of developing guidelines for red cells and plasma transfusion can be enhanced to improve implementation.

KW - AGREE II

KW - Guidelines

KW - Plasma

KW - Quality

KW - Rbc

UR - http://www.scopus.com/inward/record.url?scp=85048582257&partnerID=8YFLogxK

U2 - 10.1016/j.tmrv.2018.05.004

DO - 10.1016/j.tmrv.2018.05.004

M3 - Review Article

VL - 32

SP - 135

EP - 143

JO - Transfusion Medicine Reviews

JF - Transfusion Medicine Reviews

SN - 0887-7963

IS - 3

ER -